Saturday, 18 December 2010

File




File may be available in the countries listed below.


Ingredient matches for File



Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of File in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 15 December 2010

Losartan / HCT Stada




Losartan/HCT Stada may be available in the countries listed below.


Ingredient matches for Losartan/HCT Stada



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Losartan/HCT Stada in the following countries:


  • Germany

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan/HCT Stada in the following countries:


  • Germany

International Drug Name Search

Atenol




Atenol may be available in the countries listed below.


Ingredient matches for Atenol



Atenolol

Atenolol is reported as an ingredient of Atenol in the following countries:


  • Brazil

  • Italy

  • Taiwan

International Drug Name Search

Tuesday, 14 December 2010

Parafon Forte DSC




In the US, Parafon Forte DSC (chlorzoxazone systemic) is a member of the drug class skeletal muscle relaxants and is used to treat Muscle Spasm.

US matches:

  • Parafon Forte DSC

Ingredient matches for Parafon Forte DSC



Chlorzoxazone

Chlorzoxazone is reported as an ingredient of Parafon Forte DSC in the following countries:


  • India

  • United States

International Drug Name Search

Friday, 10 December 2010

Adriblastina RTU




Adriblastina RTU may be available in the countries listed below.


Ingredient matches for Adriblastina RTU



Doxorubicin

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Adriblastina RTU in the following countries:


  • Chile

International Drug Name Search

Pravastatin Na Kobayashi




Pravastatin Na Kobayashi may be available in the countries listed below.


Ingredient matches for Pravastatin Na Kobayashi



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatin Na Kobayashi in the following countries:


  • Japan

International Drug Name Search

Wednesday, 1 December 2010

Mapromil




Mapromil may be available in the countries listed below.


Ingredient matches for Mapromil



Maprotiline

Maprotiline is reported as an ingredient of Mapromil in the following countries:


  • Chile

Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Mapromil in the following countries:


  • Japan

International Drug Name Search

Tuesday, 30 November 2010

Diltam




Diltam may be available in the countries listed below.


Ingredient matches for Diltam



Diltiazem

Diltiazem is reported as an ingredient of Diltam in the following countries:


  • Peru

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltam in the following countries:


  • Ireland

International Drug Name Search

Sunday, 28 November 2010

Bartil




Bartil may be available in the countries listed below.


Ingredient matches for Bartil



Butamirate

Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of Bartil in the following countries:


  • Greece

International Drug Name Search

Mitoxantrone Baxter




Mitoxantrone Baxter may be available in the countries listed below.


Ingredient matches for Mitoxantrone Baxter



Mitoxantrone

Mitoxantrone is reported as an ingredient of Mitoxantrone Baxter in the following countries:


  • Portugal

Mitoxantrone dihydrochloride (a derivative of Mitoxantrone) is reported as an ingredient of Mitoxantrone Baxter in the following countries:


  • Greece

  • Singapore

  • Turkey

International Drug Name Search

Friday, 26 November 2010

Fenazil




Fenazil may be available in the countries listed below.


Ingredient matches for Fenazil



Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Fenazil in the following countries:


  • Italy

  • Malta

International Drug Name Search

Vandral Retard SinGad




Vandral Retard SinGad may be available in the countries listed below.


Ingredient matches for Vandral Retard SinGad



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Vandral Retard SinGad in the following countries:


  • Denmark

International Drug Name Search

Plidan




Plidan may be available in the countries listed below.


Ingredient matches for Plidan



Diazepam

Diazepam is reported as an ingredient of Plidan in the following countries:


  • Argentina

Pargeverine

Pargeverine hydrochloride (a derivative of Pargeverine) is reported as an ingredient of Plidan in the following countries:


  • Peru

  • Venezuela

International Drug Name Search

Thursday, 25 November 2010

Fringanor




Fringanor may be available in the countries listed below.


Ingredient matches for Fringanor



Lamotrigine

Lamotrigine is reported as an ingredient of Fringanor in the following countries:


  • Luxembourg

International Drug Name Search

Monday, 22 November 2010

Apo-Butorphanol




Apo-Butorphanol may be available in the countries listed below.


Ingredient matches for Apo-Butorphanol



Butorphanol

Butorphanol tartrate (a derivative of Butorphanol) is reported as an ingredient of Apo-Butorphanol in the following countries:


  • Canada

International Drug Name Search

Thursday, 18 November 2010

Cincol




Cincol may be available in the countries listed below.


Ingredient matches for Cincol



Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Cincol in the following countries:


  • Poland

Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Cincol in the following countries:


  • Poland

International Drug Name Search

Friday, 12 November 2010

Aldonar




Aldonar may be available in the countries listed below.


Ingredient matches for Aldonar



Spironolactone

Spironolactone is reported as an ingredient of Aldonar in the following countries:


  • Portugal

International Drug Name Search

Tuesday, 9 November 2010

Pentoxi Retard




Pentoxi Retard may be available in the countries listed below.


Ingredient matches for Pentoxi Retard



Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentoxi Retard in the following countries:


  • Romania

International Drug Name Search

Friday, 5 November 2010

Postuitrin




Postuitrin may be available in the countries listed below.


Ingredient matches for Postuitrin



Oxytocin

Oxytocin is reported as an ingredient of Postuitrin in the following countries:


  • Turkey

International Drug Name Search

Thursday, 4 November 2010

Piperacilina Tazobactam Combino Pharm




Piperacilina Tazobactam Combino Pharm may be available in the countries listed below.


Ingredient matches for Piperacilina Tazobactam Combino Pharm



Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Piperacilina Tazobactam Combino Pharm in the following countries:


  • Spain

Tazobactam

Tazobactam sodium salt (a derivative of Tazobactam) is reported as an ingredient of Piperacilina Tazobactam Combino Pharm in the following countries:


  • Spain

International Drug Name Search

Wednesday, 3 November 2010

Oflohexal




Oflohexal may be available in the countries listed below.


Ingredient matches for Oflohexal



Ofloxacin

Ofloxacin is reported as an ingredient of Oflohexal in the following countries:


  • Georgia

  • Germany

International Drug Name Search

Tuesday, 2 November 2010

Naropin


Naropin is a brand name of ropivacaine, approved by the FDA in the following formulation(s):


NAROPIN (ropivacaine hydrochloride monohydrate - injectable; injection)



  • Manufacturer: APP PHARMS

    Approval date: September 24, 1996

    Strength(s): 10MG/ML [RLD], 2MG/ML, 5MG/ML, 7.5MG/ML

Has a generic version of Naropin been approved?


No. There is currently no therapeutically equivalent version of Naropin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Naropin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Methods and compositions for the treatment of pain utilizing ropivacaine
    Patent 5,670,524
    Issued: September 23, 1997
    Inventor(s): Eek; Arne Torsten
    Assignee(s): Astra AB
    Use of a pharmaceutically acceptable salt of ropivacaine for the manufacture of a pharmaceutical preparation with sensoric block and minimal motor blockade.
    Patent expiration dates:

    • May 26, 2014
      ✓ 
      Patent use: METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.25% BY WEIGHT OF ROPIVACAINE
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Methods and compositions for the treatment of pain utilizing ropivacaine
    Patent 5,834,489
    Issued: November 10, 1998
    Inventor(s): Eek; Arne Torsten
    Assignee(s): AB Astra
    Use of a pharmaceutically acceptable salt of ropivacaine for the manufacture of a pharmaceutical preparation with sensoric block and minimal motor blockade.
    Patent expiration dates:

    • May 26, 2014
      ✓ 
      Patent use: METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.5% BY WEIGHT OF ROPIVACAINE
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Naropin Consumer Information (Wolters Kluwer)
  • Naropin Consumer Information (Cerner Multum)
  • Naropin Advanced Consumer Information (Micromedex)
  • Ropivacaine Consumer Information (Wolters Kluwer)
  • Ropivacaine Consumer Information (Cerner Multum)
  • Ropivacaine Injection Advanced Consumer Information (Micromedex)

Monday, 1 November 2010

Betamethasone Dipropionate Lotion



Pronunciation: bay-ta-METH-a-sone die-PRO-pee-oh-nate
Generic Name: Betamethasone Dipropionate
Brand Name: Generic only. No brands available.


Betamethasone Dipropionate Lotion is used for:

Reducing itching, redness, and swelling associated with many skin conditions.


Betamethasone Dipropionate Lotion is a topical corticosteroid. It works by depressing the formation, release, and activity of different cells and chemicals that cause swelling, redness, and itching.


Do NOT use Betamethasone Dipropionate Lotion if:


  • you are allergic to any ingredient in Betamethasone Dipropionate Lotion or to another corticosteroid (eg, prednisone)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Betamethasone Dipropionate Lotion:


Some medical conditions may interact with Betamethasone Dipropionate Lotion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have thinning of the skin, a skin infection, tuberculosis, chickenpox, shingles, measles, a positive TB skin test, or have recently been vaccinated

Some MEDICINES MAY INTERACT with Betamethasone Dipropionate Lotion. Because little, if any, of Betamethasone Dipropionate Lotion is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Betamethasone Dipropionate Lotion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Betamethasone Dipropionate Lotion:


Use Betamethasone Dipropionate Lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Shake well before each use.

  • Place nozzle of the bottle very close to the affected area and gently squeeze a small amount of medicine onto the affected area. Do not touch the nozzle to the skin. Gently rub the medicine in until it is evenly distributed. Wash your hands after applying Betamethasone Dipropionate Lotion, unless your hands are part of the treated area. Do not apply Betamethasone Dipropionate Lotion to the face, groin, or armpit unless otherwise directed by your doctor.

  • Do not cover the treating area with bandages, wrappings, or other dressings unless advised to do so by your health care provider.

  • If you miss a dose of Betamethasone Dipropionate Lotion, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Betamethasone Dipropionate Lotion.



Important safety information:


  • Betamethasone Dipropionate Lotion is for external use only. Avoid contact with the eyes. If you get Betamethasone Dipropionate Lotion in your eyes, immediately flush with cool tap water.

  • Do not use Betamethasone Dipropionate Lotion for other skin conditions at a later time.

  • Betamethasone Dipropionate Lotion has a corticosteroid in it. Before you start any new medicine, check the label to see if it has a corticosteroid in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • If Betamethasone Dipropionate Lotion was prescribed to treat the diaper area of a child, avoid using tight-fitting diapers or plastic pants.

  • Check with your doctor before you have any vaccinations while you are using Betamethasone Dipropionate Lotion.

  • Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they use Betamethasone Dipropionate Lotion.

  • Betamethasone Dipropionate Lotion should not be used in CHILDREN younger than 13 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Betamethasone Dipropionate Lotion while you are pregnant. It is not known if Betamethasone Dipropionate Lotion is found in breast milk. If you are or will be breast-feeding while you use Betamethasone Dipropionate Lotion, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Betamethasone Dipropionate Lotion:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dry skin; mild, temporary stinging when applied.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; burning, cracking, irritation, or peeling not present before you began using Betamethasone Dipropionate Lotion; excessive hair growth; inflamed hair follicles; inflammation around the mouth; muscle weakness; thinning, softening, or discoloration of the skin; unusual weight gain, especially in the face.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include increased thirst or urination; muscle weakness; unusual weight gain, especially in the face.


Proper storage of Betamethasone Dipropionate Lotion:

Store Betamethasone Dipropionate Lotion at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not freeze. Keep Betamethasone Dipropionate Lotion out of the reach of children and away from pets.


General information:


  • If you have any questions about Betamethasone Dipropionate Lotion, please talk with your doctor, pharmacist, or other health care provider.

  • Betamethasone Dipropionate Lotion is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Betamethasone Dipropionate Lotion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Betamethasone Dipropionate resources


  • Betamethasone Dipropionate Use in Pregnancy & Breastfeeding
  • Betamethasone Dipropionate Drug Interactions
  • Betamethasone Dipropionate Support Group
  • 13 Reviews for Betamethasone Dipropionate - Add your own review/rating


Compare Betamethasone Dipropionate with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Dermatological Disorders
  • Lichen Planus
  • Lichen Sclerosus

Tuesday, 26 October 2010

Spiramycine Métronidazole Ratiopharm




Spiramycine Métronidazole Ratiopharm may be available in the countries listed below.


Ingredient matches for Spiramycine Métronidazole Ratiopharm



Metronidazole

Metronidazole is reported as an ingredient of Spiramycine Métronidazole Ratiopharm in the following countries:


  • France

Spiramycin

Spiramycin is reported as an ingredient of Spiramycine Métronidazole Ratiopharm in the following countries:


  • France

International Drug Name Search

Wednesday, 20 October 2010

Tefmetin




Tefmetin may be available in the countries listed below.


Ingredient matches for Tefmetin



Trimebutine

Trimebutine maleate (a derivative of Trimebutine) is reported as an ingredient of Tefmetin in the following countries:


  • Japan

International Drug Name Search

Saturday, 16 October 2010

Dipezona




Dipezona may be available in the countries listed below.


Ingredient matches for Dipezona



Diazepam

Diazepam is reported as an ingredient of Dipezona in the following countries:


  • Argentina

International Drug Name Search

Friday, 15 October 2010

Repliva 21/7


Pronunciation: EYE-urn/sux-IN-ic AS-id/VYE-ta-min C/FOE-lik AS-id/VYE-ta-min B 12
Generic Name: Iron/Succinic Acid/Vitamin C/Folic Acid/Vitamin B12
Brand Name: Examples include Chromagen Forte and Repliva 21/7

Accidental overdose of products that contain iron is a leading cause of fatal poisoning in children younger than 6 years old. Keep this and all medicines out of the reach of children. In case of accidental ingestion, call the poison control center or a doctor at once.





Repliva 21/7 is used for:

Treating certain types of anemia that can be helped by increasing the amount of iron in the body (eg, anemia caused by pregnancy, blood loss, low dietary iron, metabolic disease, surgery). It may also be used for other conditions as determined by your doctor.


Repliva 21/7 is a combination of vitamins and minerals. It works by replacing iron in the body.


Do NOT use Repliva 21/7 if:


  • you are allergic to any ingredient in Repliva 21/7

  • you have too much iron in your body (eg, hemosiderosis, hemochromatosis)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Repliva 21/7:


Some medical conditions may interact with Repliva 21/7. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have another type of anemia (eg, pernicious anemia, megaloblastic anemia, hemolytic anemia)

  • if you have stomach or bowel problems (eg, inflammation, Crohn disease, ulcer), metabolism problems, porphyria, or a blood disease (eg, thalassemia)

  • if you have had multiple blood transfusions

Some MEDICINES MAY INTERACT with Repliva 21/7. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Fluorouracil because the risk of its side effects may be increased by Repliva 21/7

  • Doxycycline, hydantoins (eg, phenytoin), mycophenolate, penicillamine, or thyroid hormones (eg, levothyroxine) because their effectiveness may be decreased by Repliva 21/7

This may not be a complete list of all interactions that may occur. Ask your health care provider if Repliva 21/7 may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Repliva 21/7:


Use Repliva 21/7 as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Repliva 21/7 by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Swallow Repliva 21/7 whole. Do not break, crush, or chew before swallowing.

  • Take Repliva 21/7 with a full glass of water (8 oz/240 mL). Do not lie down for 30 minutes after taking Repliva 21/7.

  • If you also take cefdinir, methyldopa, a quinolone antibiotic (eg, ciprofloxacin), or a tetracycline antibiotic (eg, minocycline), ask your doctor or pharmacist how to take it with Repliva 21/7.

  • If you miss a dose of Repliva 21/7, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Repliva 21/7.



Important safety information:


  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Do not take large doses of vitamins while you take Repliva 21/7 unless your doctor tells you to.

  • Repliva 21/7 may cause your stools to darken. This is normal and not a cause for concern.

  • Repliva 21/7 may interfere with certain lab tests, such as tests used to check for blood in the stool. Make sure your doctor and lab personnel know you are using Repliva 21/7.

  • Lab tests, including blood counts and iron levels, may be performed while you use Repliva 21/7. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Repliva 21/7 should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Repliva 21/7 while you are pregnant. Repliva 21/7 is found in breast milk. If you are or will be breast-feeding while you use Repliva 21/7, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Repliva 21/7:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; darkened or green stools; diarrhea; nausea; stomach upset; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; blood or streaks of blood in the stool; severe or persistent vomiting or stomach pain.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Repliva 21/7 side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include black, tarry stools; chest pain; coma; dizziness; fast heartbeat; fever; increased or decreased urination; increased thirst or hunger; seizures; severe nausea, vomiting, diarrhea, or stomach pain; shortness of breath; sluggishness; trouble breathing; unusual tiredness or drowsiness; unusually pale skin; weak pulse.


Proper storage of Repliva 21/7:

Store Repliva 21/7 at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Repliva 21/7 out of the reach of children and away from pets.


General information:


  • If you have any questions about Repliva 21/7, please talk with your doctor, pharmacist, or other health care provider.

  • Repliva 21/7 is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Repliva 21/7. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Repliva 21/7 resources


  • Repliva 21/7 Side Effects (in more detail)
  • Repliva 21/7 Use in Pregnancy & Breastfeeding
  • Repliva 21/7 Drug Interactions
  • Repliva 21/7 Support Group
  • 2 Reviews for Repliva 21/7 - Add your own review/rating


  • multivitamin with iron Concise Consumer Information (Cerner Multum)

  • Allbee-C 800 with Iron Concise Consumer Information (Cerner Multum)

  • Ferotrin Prescribing Information (FDA)

  • Ferralet 90 Prescribing Information (FDA)

  • Ferrex 150 Forte Prescribing Information (FDA)

  • Ferrex 150 Forte Plus Prescribing Information (FDA)

  • Ferrex 28 Prescribing Information (FDA)

  • FerroGels Forte Prescribing Information (FDA)

  • Hematogen Forte Prescribing Information (FDA)

  • Integra F Prescribing Information (FDA)

  • Integra Plus Prescribing Information (FDA)

  • Irospan 24/6 Prescribing Information (FDA)

  • NovaFerrum Prescribing Information (FDA)

  • Tricon Prescribing Information (FDA)



Compare Repliva 21/7 with other medications


  • Anemia
  • Vitamin/Mineral Supplementation and Deficiency

Wednesday, 13 October 2010

Roxithromycine Sandoz




Roxithromycine Sandoz may be available in the countries listed below.


Ingredient matches for Roxithromycine Sandoz



Roxithromycin

Roxithromycin is reported as an ingredient of Roxithromycine Sandoz in the following countries:


  • France

International Drug Name Search

Monday, 11 October 2010

Femoston Conti




Femoston Conti may be available in the countries listed below.


Ingredient matches for Femoston Conti



Dydrogesterone

Dydrogesterone is reported as an ingredient of Femoston Conti in the following countries:


  • Finland

Estradiol

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Femoston Conti in the following countries:


  • Finland

International Drug Name Search

Saturday, 9 October 2010

Pantosec-D




Pantosec-D may be available in the countries listed below.


Ingredient matches for Pantosec-D



Domperidone

Domperidone is reported as an ingredient of Pantosec-D in the following countries:


  • India

Pantoprazole

Pantoprazole is reported as an ingredient of Pantosec-D in the following countries:


  • India

International Drug Name Search

Wednesday, 6 October 2010

Mono Mack retard




Mono Mack retard may be available in the countries listed below.


Ingredient matches for Mono Mack retard



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Mono Mack retard in the following countries:


  • Austria

International Drug Name Search

Tuesday, 28 September 2010

Morantel Tartrate




Morantel Tartrate may be available in the countries listed below.


Ingredient matches for Morantel Tartrate



Morantel

Morantel Tartrate (BANM, USAN) is also known as Morantel (Prop.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 27 September 2010

Iron Poisoning, Chronic Medications


Drugs associated with Iron Poisoning, Chronic

The following drugs and medications are in some way related to, or used in the treatment of Iron Poisoning, Chronic. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Thursday, 23 September 2010

Rasilez




Rasilez may be available in the countries listed below.


UK matches:

  • Rasilez tablets 150 mg and 300 mg (SPC)

Ingredient matches for Rasilez



Aliskiren

Aliskiren is reported as an ingredient of Rasilez in the following countries:


  • Austria

  • Denmark

  • Germany

  • Netherlands

  • Norway

  • Singapore

  • Slovenia

  • Spain

Aliskiren hemifumarate (a derivative of Aliskiren) is reported as an ingredient of Rasilez in the following countries:


  • Belgium

  • Canada

  • Croatia (Hrvatska)

  • Indonesia

  • Ireland

  • Sweden

  • Switzerland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 20 September 2010

Microlut




Microlut may be available in the countries listed below.


Ingredient matches for Microlut



Levonorgestrel

Levonorgestrel is reported as an ingredient of Microlut in the following countries:


  • Argentina

  • Australia

  • Belgium

  • Colombia

  • Dominican Republic

  • Germany

  • Indonesia

  • Ireland

  • Luxembourg

  • Mexico

  • New Zealand

  • Russian Federation

International Drug Name Search

Saturday, 11 September 2010

Femtozone




Femtozone may be available in the countries listed below.


Ingredient matches for Femtozone



Letrozole

Letrozole is reported as an ingredient of Femtozone in the following countries:


  • Slovakia

International Drug Name Search

Thursday, 9 September 2010

Prigost




Prigost may be available in the countries listed below.


Ingredient matches for Prigost



Bromocriptine

Bromocriptine mesilate (a derivative of Bromocriptine) is reported as an ingredient of Prigost in the following countries:


  • Chile

International Drug Name Search

Sipcar




Sipcar may be available in the countries listed below.


Ingredient matches for Sipcar



Bromazepam

Bromazepam is reported as an ingredient of Sipcar in the following countries:


  • Argentina

International Drug Name Search

Wednesday, 8 September 2010

Venlafab




Venlafab may be available in the countries listed below.


Ingredient matches for Venlafab



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafab in the following countries:


  • Austria

International Drug Name Search

Monday, 6 September 2010

AB-Fortimicin




AB-Fortimicin may be available in the countries listed below.


Ingredient matches for AB-Fortimicin



Ampicillin

Ampicillin benzathine and sodium salt (a derivative of Ampicillin) is reported as an ingredient of AB-Fortimicin in the following countries:


  • Peru

International Drug Name Search

Sunday, 5 September 2010

Defencat




Defencat may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Defencat



Permethrin

Permethrin is reported as an ingredient of Defencat in the following countries:


  • Portugal

  • United Kingdom

International Drug Name Search

Saturday, 4 September 2010

Mycostatin Evt




Mycostatin Evt may be available in the countries listed below.


Ingredient matches for Mycostatin Evt



Nystatin

Nystatin is reported as an ingredient of Mycostatin Evt in the following countries:


  • Taiwan

International Drug Name Search

Friday, 3 September 2010

Reocef




Reocef may be available in the countries listed below.


Ingredient matches for Reocef



Cefradine

Cefradine is reported as an ingredient of Reocef in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, 28 August 2010

Gaïacol




Gaïacol may be available in the countries listed below.


Ingredient matches for Gaïacol



Guaiacol

Gaïacol (DCF) is also known as Guaiacol (Ph. Eur.)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Ph. Eur.European Pharmacopoeia

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 25 August 2010

ChlorMax




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for ChlorMax



Bacitracin

Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of ChlorMax in the following countries:


  • United States

Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of ChlorMax in the following countries:


  • United States

Chlortetracycline

Chlortetracycline is reported as an ingredient of ChlorMax in the following countries:


  • United States

Chlortetracycline calcium salt (a derivative of Chlortetracycline) is reported as an ingredient of ChlorMax in the following countries:


  • United States

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of ChlorMax in the following countries:


  • United States

Decoquinate

Decoquinate is reported as an ingredient of ChlorMax in the following countries:


  • United States

Monensin

Monensin sodium salt (a derivative of Monensin) is reported as an ingredient of ChlorMax in the following countries:


  • United States

Salinomycin

Salinomycin sodium salt (a derivative of Salinomycin) is reported as an ingredient of ChlorMax in the following countries:


  • United States

Sulfadimidine

Sulfadimidine is reported as an ingredient of ChlorMax in the following countries:


  • United States

International Drug Name Search

Algoremin




Algoremin may be available in the countries listed below.


Ingredient matches for Algoremin



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Algoremin in the following countries:


  • Romania

International Drug Name Search

Sunday, 22 August 2010

Acenocumarolo




Acenocumarolo may be available in the countries listed below.


Ingredient matches for Acenocumarolo



Acenocoumarol

Acenocumarolo (DCIT) is also known as Acenocoumarol (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 4 August 2010

Betadona




Betadona may be available in the countries listed below.


Ingredient matches for Betadona



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Betadona in the following countries:


  • Austria

International Drug Name Search

Monday, 26 July 2010

Dipidolor




Dipidolor may be available in the countries listed below.


Ingredient matches for Dipidolor



Piritramide

Piritramide is reported as an ingredient of Dipidolor in the following countries:


  • Austria

  • Belgium

  • Czech Republic

  • Germany

  • Luxembourg

  • Netherlands

International Drug Name Search

Sunday, 25 July 2010

Lamotrigin Desitin




Lamotrigin Desitin may be available in the countries listed below.


Ingredient matches for Lamotrigin Desitin



Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigin Desitin in the following countries:


  • Germany

  • Switzerland

International Drug Name Search

Rodizim




Rodizim may be available in the countries listed below.


Ingredient matches for Rodizim



Clarithromycin

Clarithromycin is reported as an ingredient of Rodizim in the following countries:


  • Belize

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

International Drug Name Search

Thursday, 22 July 2010

Decaspot




Decaspot may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Decaspot



Deltamethrin

Deltamethrin is reported as an ingredient of Decaspot in the following countries:


  • South Africa

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Decaspot in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 21 July 2010

Remeron SolTab


See also: Generic Remeron


Remeron SolTab is a brand name of mirtazapine, approved by the FDA in the following formulation(s):


REMERON SOLTAB (mirtazapine - tablet, orally disintegrating; oral)



  • Manufacturer: ORGANON USA INC

    Approval date: January 12, 2001

    Strength(s): 15MG [RLD][AB], 30MG [AB], 45MG [AB]

Has a generic version of Remeron SolTab been approved?


Yes. The following products are equivalent to Remeron SolTab:


mirtazapine tablet, orally disintegrating; oral



  • Manufacturer: ACTAVIS ELIZABETH

    Approval date: February 14, 2011

    Strength(s): 15MG [AB], 30MG [AB], 45MG [AB]


  • Manufacturer: AUROBINDO PHARMA LTD

    Approval date: December 8, 2005

    Strength(s): 15MG [AB], 30MG [AB]


  • Manufacturer: AUROBINDO PHARMA LTD

    Approval date: February 28, 2006

    Strength(s): 45MG [AB]


  • Manufacturer: TEVA

    Approval date: June 28, 2005

    Strength(s): 15MG [AB], 30MG [AB], 45MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: December 17, 2003

    Strength(s): 15MG [AB], 30MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: February 28, 2006

    Strength(s): 45MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Remeron SolTab. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Remeron SolTab.

See also...

  • Remeron SolTab Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Remeron SolTab Consumer Information (Cerner Multum)
  • Remeron Soltab Advanced Consumer Information (Micromedex)
  • Mirtazapine Consumer Information (Wolters Kluwer)
  • Mirtazapine Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Mirtazapine Consumer Information (Cerner Multum)
  • Remeron RD Advanced Consumer Information (Micromedex)
  • Mirtazapine Advanced Consumer Information (Micromedex)
  • Mirtazapine AHFS DI Monographs (ASHP)

Tuesday, 20 July 2010

Tachmalcor




Tachmalcor may be available in the countries listed below.


Ingredient matches for Tachmalcor



Detajmium Bitartrate

Detajmium Bitartrate is reported as an ingredient of Tachmalcor in the following countries:


  • Czech Republic

  • Germany

International Drug Name Search

Mefac




Mefac may be available in the countries listed below.


Ingredient matches for Mefac



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Mefac in the following countries:


  • Bahrain

  • Cyprus

  • Egypt

  • Ireland

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Peru

  • Qatar

  • Saudi Arabia

  • United Arab Emirates

  • Yemen

International Drug Name Search

Saturday, 17 July 2010

Metipranolol




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01ED04

CAS registry number (Chemical Abstracts Service)

0022664-55-7

Chemical Formula

C17-H27-N-O4

Molecular Weight

309

Therapeutic Categories

ß-Adrenergic blocking agent

Glaucoma treatment

Chemical Name

Phenol, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-2,3,6-trimethyl-, 1-acetate

Foreign Names

  • Metipranololum (Latin)
  • Metipranolol (German)
  • Métipranolol (French)
  • Metipranolol (Spanish)

Generic Names

  • Metipranolol (OS: USAN, BAN)
  • Métipranolol (OS: DCF)
  • Metipranololo (OS: DCIT)
  • BM 01.004 (IS)
  • Methypranol (IS)
  • VUAB 6453 (IS: Spofa)
  • VUFB 6453 (IS)
  • Metipranolol (PH: BP 2010)

Brand Names

  • Betacarpin (Metipranolol and Pilocarpine)
    Riel, Austria


  • Betamann
    Mann, Luxembourg


  • Betanol
    Europhta, Monaco


  • Bétanol
    Europhta, Monaco


  • Betaophthiole
    Kite, Greece


  • Beta-Ophtiole
    Bausch & Lomb, South Africa


  • Minims Metipranolol
    Chauvin, United Kingdom


  • OptiPrandol
    Bausch & Lomb, United States


  • Trimepranol
    Biotika, Slovakia; Glenmark, Slovakia; Slovakofarma, Czech Republic; Zentiva, Czech Republic


  • Turoptin
    Bausch & Lomb, Italy; Novartis, Turkey


  • Beta Ophtiole
    Tramedico, Belgium; Tramedico, Netherlands


  • Betamann
    Dr. Mann, Poland; Mann, Germany


  • Betamann EDO
    Mann, Germany


  • Beta-Ophtiole
    Angelini, Portugal; Mann, Taiwan; Riel, Austria


  • Normoglaucon (Metipranolol and Pilocarpine)
    Tramedico, Belgium; Tramedico, Netherlands

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 10 July 2010

desirudin Subcutaneous


des-i-ROO-din


Subcutaneous route(Powder for Solution)

Epidural or spinal hematomas, which may result in long-term or permanent paralysis, may occur in patients who are anticoagulated with selective thrombin inhibitors and are undergoing neuraxial anesthesia or spinal puncture. The risk of developing these hematomas is increased with the use of indwelling epidural catheters and concomitant use of drugs affecting hemostasis. Monitor patients frequently for neurological impairment and treat immediately if neurological compromise is noted. Consider risks/benefits before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis .



Commonly used brand name(s)

In the U.S.


  • Iprivask

Available Dosage Forms:


  • Powder for Solution

Pharmacologic Class: Thrombin Inhibitor, Direct


Chemical Class: Hirudin Related


Uses For desirudin


Desirudin is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism. desirudin is used for several days after hip replacement surgery, while you are unable to walk. It is during this time that blood clots are most likely to form.


desirudin is available only with your doctor's prescription.


Before Using desirudin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For desirudin, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to desirudin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of desirudin in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of desirudin in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving desirudin.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking desirudin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using desirudin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abciximab

  • Alteplase, Recombinant

  • Anistreplase

  • Aspirin

  • Chamomile

  • Cilostazol

  • Citalopram

  • Clopidogrel

  • Dabigatran Etexilate

  • Desvenlafaxine

  • Diclofenac

  • Dipyridamole

  • Eptifibatide

  • Escitalopram

  • Etodolac

  • Fenoprofen

  • Fluoxetine

  • Flurbiprofen

  • Fluvoxamine

  • Garlic

  • Ginkgo

  • Ibuprofen

  • Indomethacin

  • Ketoprofen

  • Ketorolac

  • Meclofenamate

  • Mefenamic Acid

  • Meloxicam

  • Milnacipran

  • Nabumetone

  • Naproxen

  • Oxaprozin

  • Papaya

  • Paroxetine

  • Piroxicam

  • Prasugrel

  • Reteplase, Recombinant

  • Rivaroxaban

  • Sertraline

  • St John's Wort

  • Streptokinase

  • Sulfinpyrazone

  • Sulindac

  • Tan-Shen

  • Tenecteplase

  • Ticlopidine

  • Tirofiban

  • Tolmetin

  • Urokinase

  • Venlafaxine

Using desirudin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Avocado

  • Chondroitin

  • Coenzyme Q10

  • Curcumin

  • Dong Quai

  • Ginger

  • Green Tea

  • Vitamin A

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of desirudin. Make sure you tell your doctor if you have any other medical problems, especially:


  • Blood clotting disorders or

  • Major bleeding, active—Should not be used in patients with these conditions.

  • Blood disease or bleeding problems (e.g., hemophilia) or

  • Catheter insertion in your spine or

  • Eye problems caused by diabetes or

  • Heart infection (e.g., bacterial endocarditis) or

  • Hypertension (high blood pressure), severe and uncontrolled or

  • Liver disease or

  • Major surgery procedure (e.g., organ biopsy), recent or history of or

  • Stomach or intestinal ulcer, history of or

  • Stroke, recent or history of or

  • Surgery (e.g., surgery of the eye, brain, or spine), recent or history of—Use with caution. The risk of bleeding may be increased.

  • Kidney disease—Use with caution. The effects may be increased because of slower removal from the body.

Proper Use of desirudin


A nurse or other trained health professional will give you desirudin. desirudin is given as a shot under your skin, usually in the abdomen or thighs.


If you are using desirudin at home, your doctor will teach you how to inject yourself with the medicine. Be sure to follow the directions carefully. Check with your doctor if you have any problems using the medicine.


You will be shown the body areas where this shot can be given. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas. This will help prevent skin problems from the injections.


Use only the brand of desirudin that your doctor prescribed. Different brands may not work the same way.


If the medicine in the vial (glass container) or prefilled syringe has changed color, or if you see particles in it, do not use it.


Put used syringes in a puncture-resistant, disposable container, or dispose of them as directed by your doctor.


Dosing


The dose of desirudin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of desirudin. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For prevention of deep venous thrombosis (leg clots) after hip replacement surgery:
      • Adults—15 milligrams (mg) injected under the skin every 12 hours. The dose is 1.7 to 5 mg every 12 hours if you have a poorly performing kidney.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


Call your doctor or pharmacist for instructions.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the unopened vials or prefilled syringes at room temperature, away from heat, moisture, and direct light. You may also store the mixed solution at room temperature and may be used up to 24 hours. Throw away any unused medicine after 24 hours.


Throw away used needles in a hard, closed container that the needles cannot poke through. Keep this container away from children and pets.


Precautions While Using desirudin


It is very important that your doctor check your progress at regular visits to make sure desirudin is working properly. Blood tests will be needed to check for unwanted effects. Be sure to keep all appointments.


desirudin may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Tell your doctor right away if you have a rash; itching; swelling of the face, tongue, and throat; trouble breathing; or chest pain after you receive desirudin.


Make sure your doctor knows if you have had an allergic reaction to similar medicines such as bivalirudin, lepirudin, Angiomax®, Angiox®, or Refludan®.


Desirudin may increase your chance of bleeding or bruising. This risk is higher if you have a catheter in your back for pain medicine or anesthesia (sometimes called an "epidural"), or if you have kidney problems. The risk of bleeding increases as the severity of your kidney problems increases. Check with your doctor right away if you notice any unusual bleeding or bruising; black, tarry stools; bleeding gums; blood in the urine or stools; or pinpoint red spots on your skin.


You may bleed and bruise more easily while you are using desirudin. Stay away from rough sports or other situations where you could be bruised, cut, or injured. Be careful when using sharp objects, including razors and fingernail clippers. Avoid nose picking and forceful nose blowing.


Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.


Make sure any doctor or dentist who treats you knows that you are using desirudin. You may need to stop using desirudin several days before having surgery or medical tests.


Do not take or discontinue other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines, and herbal or vitamin supplements.


desirudin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Bleeding gums

  • collection of blood under the skin

  • coughing up blood

  • deep, dark purple bruise

  • difficulty with breathing or swallowing

  • dizziness

  • headache

  • increased menstrual flow or vaginal bleeding

  • itching, pain, redness, or swelling

  • nosebleeds

  • paralysis

  • prolonged bleeding from cuts

  • red or black, tarry stools

  • red or dark brown urine

  • shortness of breath

Less common
  • Changes in skin color, pain, tenderness, or swelling of the foot or leg

  • cough

  • fast heartbeat

  • hives

  • pale skin

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • skin rash

  • tightness in the chest

  • troubled breathing with exertion

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • wheezing

  • wound secretion

Less common or rare
  • Blood in the urine

  • blurred vision

  • confusion

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • fever

  • severe or sudden headache

  • sudden loss of coordination

  • sudden slurring of speech

  • sweating

  • tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over affected area

  • trouble healing

  • vomiting of blood or material that looks like coffee grounds

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Nausea

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: desirudin Subcutaneous side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More desirudin Subcutaneous resources


  • Desirudin Subcutaneous Side Effects (in more detail)
  • Desirudin Subcutaneous Use in Pregnancy & Breastfeeding
  • Desirudin Subcutaneous Drug Interactions
  • Desirudin Subcutaneous Support Group
  • 0 Reviews for Desirudin Subcutaneous - Add your own review/rating


Compare desirudin Subcutaneous with other medications


  • Deep Vein Thrombosis, Prophylaxis

Ergotamina




Ergotamina may be available in the countries listed below.


Ingredient matches for Ergotamina



Ergotamine

Ergotamina (DCIT) is known as Ergotamine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 7 July 2010

Valbantel




Valbantel may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Valbantel



Albendazole

Albendazole is reported as an ingredient of Valbantel in the following countries:


  • South Africa

Closantel

Closantel sodium salt (a derivative of Closantel) is reported as an ingredient of Valbantel in the following countries:


  • South Africa

International Drug Name Search

Monday, 28 June 2010

Dycill


Generic Name: dicloxacillin (dye klox a SIL in)

Brand Names: Dycill, Dynapen


What is Dycill (dicloxacillin)?

Dicloxacillin is an antibiotic in the penicillin group of drugs. It fights bacteria in your body.


Dicloxacillin is used to treat many different types of infections caused by bacteria such as bronchitis, pneumonia, or staphylococcal (also called "staph") infections.


Dicloxacillin may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Dycill (dicloxacillin)?


Do not use this medication if you are allergic to dicloxacillin or to any other penicillin antibiotic, such as amoxicillin (Amoxil), ampicillin (Omnipen, Principen), carbenicillin (Geocillin), oxacillin (Bactocill), penicillin (Beepen-VK, Ledercillin VK, Pen-V, Pen-Vee K, Pfizerpen, V-Cillin K, Veetids), and others.

Before using dicloxacillin, tell your doctor if you are allergic to cephalosporins such as Ceclor, Ceftin, Duricef, Keflex, and others, or if you have asthma, liver disease, kidney disease, or a history of any type of allergy.


Dicloxacillin can make birth control pills less effective, which may result in pregnancy. Before taking dicloxacillin, tell your doctor if you use birth control pills. Take this medication for the entire length of time prescribed by your doctor. Your symptoms may get better before the infection is completely treated. Dicloxacillin will not treat a viral infection such as the common cold or flu. Do not share this medication with another person, even if they have the same symptoms you have.

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or has blood in it, call your doctor. Do not use any medicine to stop the diarrhea unless your doctor has told you to.


What should I discuss with my healthcare provider before taking Dycill (dicloxacillin)?


Do not use this medication if you are allergic to dicloxacillin or to any other penicillin antibiotic, such as:

  • amoxicillin (Amoxil, Amoxicot, Biomox, Dispermox, Trimox);




  • ampicillin (Omnipen, Principen);




  • carbenicillin (Geocillin);




  • oxacillin (Bactocill); or




  • penicillin (Beepen-VK, Ledercillin VK, Pen-V, Pen-Vee K, Pfizerpen, V-Cillin K, Veetids, and others).



Before using dicloxacillin, tell your doctor if you are allergic to any drugs (especially cephalosporins such as Ceclor, Ceftin, Duricef, Keflex, and others), or if you have:



  • asthma;




  • liver disease;




  • kidney disease;




  • a bleeding or blood clotting disorder;




  • a history of diarrhea caused by taking antibiotics; or




  • a history of any type of allergy.



If you have any of these conditions, you may need a dose adjustment or special tests to safely take dicloxacillin.


FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Dicloxacillin can make birth control pills less effective, which may result in pregnancy. Before taking dicloxacillin, tell your doctor if you use birth control pills. Dicloxacillin can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Dycill (dicloxacillin)?


Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.


Take the medicine with a full glass of water. Dicloxacillin should be taken on an empty stomach, at least 1 hour before or 2 hours after eating a meal.

To be sure this medication is helping your condition, your blood will need to be tested on a regular basis. Your kidney or liver function may also need to be tested. Do not miss any scheduled visits to your doctor.


Take this medication for the entire length of time prescribed by your doctor. Your symptoms may get better before the infection is completely treated. Dicloxacillin will not treat a viral infection such as the common cold or flu. Do not share this medication with another person, even if they have the same symptoms you have.

This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using dicloxacillin.


Store dicloxacillin at room temperature away from moisture, heat, and light.

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include confusion, behavior changes, a severe skin rash, urinating less than usual, or seizure (black-out or convulsions).


What should I avoid while taking Dycill (dicloxacillin)?


Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or has blood in it, call your doctor. Do not use any medicine to stop the diarrhea unless your doctor has told you to.


Dycill (dicloxacillin) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);




  • diarrhea that is watery or bloody;




  • fever, chills, body aches, flu symptoms;




  • easy bruising or bleeding, unusual weakness;




  • urinating less than usual or not at all;




  • severe skin rash, itching, or peeling;




  • agitation, confusion, unusual thoughts or behavior; or




  • seizure (black-out or convulsions).



Less serious side effects may include:



  • nausea, vomiting, stomach pain;




  • vaginal itching or discharge;




  • headache;




  • swollen, black, or "hairy" tongue; or




  • thrush (white patches or inside your mouth or throat).



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dycill (dicloxacillin)?


Before taking dicloxacillin, tell your doctor if you are using any of the following drugs:



  • methotrexate (Rheumatrex, Trexall); or




  • probenecid (Benemid).



This list is not complete and there may be other drugs that can interact with dicloxacillin. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More Dycill resources


  • Dycill Side Effects (in more detail)
  • Dycill Use in Pregnancy & Breastfeeding
  • Drug Images
  • Dycill Drug Interactions
  • Dycill Support Group
  • 0 Reviews for Dycill - Add your own review/rating


  • Dicloxacillin Prescribing Information (FDA)

  • Dicloxacillin MedFacts Consumer Leaflet (Wolters Kluwer)

  • Dicloxacillin Sodium Monograph (AHFS DI)

  • Dynapen Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Dycill with other medications


  • Bone infection
  • Bronchitis
  • Pharyngitis
  • Pneumonia
  • Skin Infection
  • Upper Respiratory Tract Infection


Where can I get more information?


  • Your pharmacist can provide more information about dicloxacillin.

See also: Dycill side effects (in more detail)